The mTOR Inhibitor Rapamycin Synergizes With a Fatty Acid Synthase Inhibitor to Induce Cytotoxicity in ER/HER2-Positive Breast Cancer Cells
PLoS ONE - United States
doi 10.1371/journal.pone.0097697
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 27, 2014
Authors
Publisher
Public Library of Science (PLoS)